PMC:7534795 / 67129-67312
Annnotations
LitCovid-PD-FMA-UBERON
/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an ef
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T93","span":{"begin":143,"end":146},"obj":"Body_part"}],"attributes":[{"id":"A93","pred":"uberon_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/UBERON_0000978"}],"text":"/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an ef"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T440","span":{"begin":147,"end":153},"obj":"Disease"}],"attributes":[{"id":"A440","pred":"mondo_id","subj":"T440","obj":"http://purl.obolibrary.org/obo/MONDO_0043839"}],"text":"/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an ef"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T410","span":{"begin":27,"end":33},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T411","span":{"begin":143,"end":146},"obj":"http://www.ebi.ac.uk/efo/EFO_0001411"}],"text":"/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an ef"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T332","span":{"begin":5,"end":8},"obj":"Chemical"},{"id":"T29542","span":{"begin":44,"end":46},"obj":"Chemical"},{"id":"T70242","span":{"begin":50,"end":52},"obj":"Chemical"},{"id":"T99746","span":{"begin":169,"end":174},"obj":"Chemical"}],"attributes":[{"id":"A96623","pred":"chebi_id","subj":"T332","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A49471","pred":"chebi_id","subj":"T332","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A69465","pred":"chebi_id","subj":"T332","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A98201","pred":"chebi_id","subj":"T332","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A93552","pred":"chebi_id","subj":"T29542","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A29662","pred":"chebi_id","subj":"T29542","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A2890","pred":"chebi_id","subj":"T70242","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A79598","pred":"chebi_id","subj":"T70242","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A33496","pred":"chebi_id","subj":"T99746","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an ef"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1995","span":{"begin":44,"end":48},"obj":"Gene"},{"id":"1996","span":{"begin":50,"end":55},"obj":"Gene"},{"id":"1997","span":{"begin":60,"end":65},"obj":"Gene"},{"id":"2003","span":{"begin":114,"end":122},"obj":"Species"},{"id":"2005","span":{"begin":5,"end":8},"obj":"Chemical"},{"id":"2014","span":{"begin":136,"end":153},"obj":"Disease"}],"attributes":[{"id":"A1995","pred":"tao:has_database_id","subj":"1995","obj":"Gene:3569"},{"id":"A1996","pred":"tao:has_database_id","subj":"1996","obj":"Gene:3552"},{"id":"A1997","pred":"tao:has_database_id","subj":"1997","obj":"Gene:7124"},{"id":"A2003","pred":"tao:has_database_id","subj":"2003","obj":"Tax:9606"},{"id":"A2005","pred":"tao:has_database_id","subj":"2005","obj":"MESH:D004281"},{"id":"A2014","pred":"tao:has_database_id","subj":"2014","obj":"MESH:D007871"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"/day DHA) markedly reduces plasma levels of IL-6, IL-1β and TNF-α after 4 weeks of therapy in middle or late-aged patients with chronic venous leg ulcers suggesting n-3 PUFAs as an ef"}